Legato Merger Corp. III (LEGT-UN) Peer Comparison
$11.18
$0.15
(1.36%)
As on 04-Dec-2025 09:47EDT
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 4,807 | 3,599 | 10 | 2 |
Revenue ($ Mln) |
-- | 1,206 | 573 | 6 | 2 |
Net Profit ($ Mln) |
8.48 | 134.79 | 147.29 | 0.07 | -18.75 |
Net Margin (%) |
-- | 11.18 | 25.72 | 1.20 | -1,003.19 |
RoE (%) |
-- | 3.43 | 25.36 | -- | -130.74 |
Price to Earnings |
-- | 37.42 | 25.53 | -- | -- |
Price-To-Book |
-- | 1.24 | 5.56 | 1,802.81 | 0.59 |
Income Statement ($ Mln)
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
-- | 943.55 | 371.48 | 2.05 | 0.00 |
|
Cost of Revenue
|
-- | 315.73 | 92.33 | 1.39 | 0.35 |
|
Gross Profit
|
-- | 627.82 | 279.16 | 0.66 | -0.35 |
|
Operating Expenses
|
0.67 | 504.09 | 287.13 | 2.33 | 4.06 |
|
Operating Profit (EBIT)
|
-0.67 | 123.73 | -7.98 | -0.27 | -4.42 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
8.22 | -22.55 | -4.63 | -0.28 | -4.47 |
|
Provision for Tax
|
-- | -3.42 | -0.07 | -- | -- |
|
Profit after Tax (Net Income)
|
8.22 | -19.13 | -4.56 | -0.28 | -5.66 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
204.87 | 3,079.79 | 358.55 | -0.17 | 2.54 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
7.04 | 1,351.59 | 5.70 | 0.37 | 0.00 |
|
Current Liabilities
|
0.02 | 145.63 | 77.34 | 0.51 | 0.27 |
|
Total Liabilities
|
211.91 | 4,577.00 | 441.58 | 0.71 | 2.81 |
Assets ($ Mln)
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
210.06 | 4,205.96 | 200.59 | 0.26 | 0.17 |
|
Current Assets
|
1.85 | 371.04 | 240.99 | 0.45 | 2.64 |
|
Total Assets
|
211.91 | 4,577.00 | 441.58 | 0.71 | 2.81 |
|
Total Debt*
|
0.01 | 1,263.21 | 0.72 | -- | 0.37 |
|
Net Current Assets
|
-- | 225.41 | 163.65 | -0.06 | 2.37 |
Cashflow ($ Mln)
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.84 | 169.77 | 32.61 | -0.06 | -5.73 |
|
Cash Flow from Investing Activities
|
-201.25 | -27.27 | -10.13 | -- | -0.12 |
|
Cash from Financing Activities
|
203.72 | 16.65 | 67.27 | 0.16 | 4.33 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
8.02 | -0.44 | -1.49 | 1,137.71 | -174.43 |
|
ROE (%)
|
8.02 | -0.75 | -1.50 | 1,137.71 | -184.96 |
|
ROA (%)
|
7.75 | -0.42 | -1.19 | -37.86 | -142.01 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -2.03 | -1.23 | -13.81 | -701.02 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 0.19 | 0.22 | 0.07 | -1.00 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-- | 62.74 | 83.83 | 90.91 | 31.40 |
|
EPS Growth (%)
|
-- | 0.65 | 0.87 | -- | -61.45 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -343.71 | -753.94 | -- | -0.58 |
|
Price / Book Value
|
-- | 2.13 | 9.58 | -- | 1.29 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
2.42 | 24.66 | 597.43 | -- | -0.31 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 0.41 | 0.00 | -- | 0.10 |
|
Short term debt to equity ratio
|
1.59 | 0.01 | 0.00 | -- | 0.05 |
|
Current Ratio
|
-- | 2.55 | 3.12 | 0.89 | 9.70 |
|
Quick Ratio
|
-- | 1.91 | 3.01 | -- | 8.53 |
|
Interest Coverage
|
-- | 0.85 | -- | -- | -- |
Operating Efficiency Ratios
| Legato Merger Corp. III (LEGT-UN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 15.69 | 16.56 | -- | 14.80 |
|
Asset Turnover
|
-- | 0.21 | 0.97 | 2.74 | 0.00 |
|
Receivable days
|
-- | 54.38 | 51.30 | -- | 43.64 |
|
Inventory Days
|
-- | -15.38 | 24.04 | -- | 557.73 |
|
Payable days
|
-- | 53.71 | 22.47 | 34.12 | 434.77 |
|
Cash Conversion Cycle
|
-- | -14.70 | 52.88 | -- | -42.03 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
